Synfacts 2010(9): 0971-0971  
DOI: 10.1055/s-0030-1257880
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of R207910

Contributor(s):Philip Kocienski
Y. Saga, R. Motoki, S. Makino, Y. Shimizu, M. Kanai*, M. Shibasaki*
The University of Tokyo, Japan
Catalytic Asymmetric Synthesis of R207910
J. Am. Chem. Soc.  2010,  132:  7905-7907  
Further Information

Publication History

Publication Date:
23 August 2010 (online)


Significance

R207910 is a selective inhibitor of the ATP synthase proton pump of both drug-sensitive and drug-resistant Mycobacterium ­tuberculosis. The synthesis of R207910 depicted features two novel transformations: (1) a catalytic enantioselective proton migration using a bimetallic Y complex (AC) and (2) a CuF-catalyzed dia­stereoselective allylation reaction (CE).

Comment

Mass spectrometric evidence suggests that the active catalyst in the enantioselective proton migration reaction (AC) is a ternary complex comprising two ytterbium atoms, three molecules of the ligand B and one molecule of 4-methoxypyridine N-oxide. A catalytic cycle for the reaction is postulated. The allylation step could be performed with as little as 1 mol% of the CuF complex at the expense of a diminished dr (5.6:1).